EMEA-002852-PIP01-20

Table of contents

Key facts

Active substance
  • Atorvastatin
  • Ezetimibe
Therapeutic area
Cardiovascular diseases
Decision number
P/0445/2020
PIP number
EMEA-002852-PIP01-20
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
  • Prevention of cardiovascular events
  • Treatment of hypercholesterolemia
Route(s) of administration
Oral use
Contact for public enquiries
Sandoz B.V.

Email: caroline.kleinjan@sandoz.com    
Tel. +31 365241710
 

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating